Opportunity Information: Apply for RFA NS 24 034
This NIH funding opportunity (RFA-NS-24-034) supports an Alzheimer s disease-related dementias (ADRD) initiative focused on creating practical, shareable tools and resources that help researchers interpret in vivo neuroimaging findings linked to vascular injury and dysfunction. The central scientific goal is to better explain the vascular pathophysiology that underlies imaging features commonly associated with vascular contributions to cognitive impairment and dementia (VCID), with an emphasis on TBI-related dementia as well as other ADRD diagnoses. In plain terms, the program is trying to close the gap between what clinicians and researchers see on scans in living people and what those findings actually mean biologically when compared against human neuropathology, so that imaging markers can be understood more accurately and used more effectively across studies and clinical contexts.
The award uses the U24 cooperative agreement mechanism, which typically means NIH will have substantial programmatic involvement and expects the funded group to operate as a resource builder and distributor for the field rather than running a traditional hypothesis-driven research project. Clinical trials are not allowed under this announcement, so applications should be structured around technology and resource development, standardization, validation, and dissemination instead of testing an intervention in humans. The kinds of outputs NIH is looking for include innovative technologies, methods, protocols, and biomedical materials that make it easier to conduct combined neuropathology and neuroimaging studies, generate high-quality data, and interpret clinically relevant imaging signals through a neuropathologically informed lens. A strong application would usually describe what will be built, how it will be tested for robustness and usability, how it will be documented, and how the broader community will access and adopt it.
A major program expectation is open data sharing and broad distribution. Resources developed under the FOA are intended to expand the overall research community s capacity, not just the awardee s lab or consortium. That implies deliverables such as well-documented pipelines, standardized acquisition or processing protocols, reference datasets, harmonized ontologies, tissue handling and imaging-to-pathology alignment procedures, quality control frameworks, or other community-facing materials that can be reused across institutions. Because the opportunity is explicitly about understanding the pathophysiology behind in vivo imaging findings tied to VCID and related processes, the work should make a clear connection between imaging observations and vascular mechanisms supported by human neuropathology evidence, enabling more confident interpretation of ARIA- and VCID-relevant neuroimaging signatures in living participants.
Eligibility is broad and includes many U.S.-based organization types: state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other eligible entities. The announcement also highlights additional eligible applicant categories such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, along with faith-based or community-based organizations and eligible federal agencies. Foreign organizations are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined by NIH policy are allowed, meaning certain well-justified international collaborations or activities may be permissible when structured as a foreign component under NIH rules.
Key administrative details include that the sponsoring agency is the National Institutes of Health, the funding instrument is a cooperative agreement, and the activity category is health. The CFDA numbers listed are 93.853 and 93.866. The original closing date provided is 2024-06-02, the opportunity was created on 2024-03-28, and the award ceiling is noted as $1,000,000. Overall, the opportunity is best understood as NIH investing in field-building infrastructure: reusable, openly shared tools and standardized resources that let many groups connect neuroimaging findings to underlying vascular biology in ADRD and TBI-related dementia research, improving interpretation, comparability, and scientific traction across studies.Apply for RFA NS 24 034
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2024-03-28.
- Applicants must submit their applications by 2024-06-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)
Previous opportunity: FY24 IIJA/IRA Bureau of Land Management Nevada (NV) Plant Conservation and Restoration Management
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 24 034
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 24 034) also looked into and applied for these:
| Funding Opportunity |
|---|
| Maximizing Access to Research Careers (MARC) (T34) Apply for PAR 24 138 Funding Number: PAR 24 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) Apply for PAR 24 137 Funding Number: PAR 24 137 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| GH Social and Behavior Change (SBC) Activity Apply for 7200AA24RFA00008 Funding Number: 7200AA24RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $321,500,000 |
| Research to Advance the Science of Primary Care (R01) Apply for PA 24 205 Funding Number: PA 24 205 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 019 Funding Number: RFA AI 24 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 021 Funding Number: RFA AI 24 021 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed) Apply for RFA AI 24 020 Funding Number: RFA AI 24 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) Apply for PAR 24 172 Funding Number: PAR 24 172 Agency: National Institutes of Health Category: Health Funding Amount: $1,515,000 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) Apply for PAR 24 173 Funding Number: PAR 24 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID Kenya and East Africa (KEA) Social and Behavior Change (SBC) Activity Apply for 72061524RFA00004 Funding Number: 72061524RFA00004 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $14,950,000 |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Apply for RFA TR 24 023 Funding Number: RFA TR 24 023 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) Apply for RFA MH 25 190 Funding Number: RFA MH 25 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 24 006 Funding Number: RFA RM 24 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) Apply for RFA TR 24 021 Funding Number: RFA TR 24 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed) Apply for PAR 24 196 Funding Number: PAR 24 196 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed) Apply for RFA AI 24 013 Funding Number: RFA AI 24 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) Apply for PAR 24 168 Funding Number: PAR 24 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed) Apply for PAR 24 198 Funding Number: PAR 24 198 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) Apply for PAR 24 203 Funding Number: PAR 24 203 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 24 139 Funding Number: PAR 24 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 24 034", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
